Skip to content
‹ Back to IndustriesHealthcare

Six Week Radiographic Comparison of HipGrid® Drone™ and PhantomMSK® Hip

OrthoGrid announces a new clinical whitepaper for review. A retrospective evaluation was conducted for a consecutive cohort of patients having undergone unilateral total hip arthroplasty via the direct anterior approach between January 2017 and January 2020. All procedures were performed at a single site, by a single, fellowship trained orthopedic surgeon. Intraoperative fluoroscopy was supplemented…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
Six Week Radiographic Comparison of HipGrid® Drone™ and PhantomMSK® Hip

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

OrthoGrid announces a new clinical whitepaper for review.

A retrospective evaluation was conducted for a consecutive cohort of patients having undergone unilateral total hip arthroplasty via the direct anterior approach between January 2017 and January 2020. All procedures were performed at a single site, by a single, fellowship trained orthopedic surgeon. Intraoperative fluoroscopy was supplemented by either the HipGrid®Drone™ (Drone) or PhantomMSK® Hip (Phantom) (OrthoGrid Systems Inc.

, Salt Lake City, UT, USA) to assist in the positioning of total hip arthroplasty components including cementless, short femoral stem and acetabular cup. The pre-defined target leg length discrepancy (LLD) and global hip offset (GHO) was less than 10mm and acetabular cup abduction angle (ABD) target was 45 degrees plus or minus 10 degrees for the Drone and 42 degrees plus or minus 10 degrees for the Phantom. Accuracy of component placement was evaluated on the six-week post-operative, weight bearing radiographs.

Fluoroscopy times were recorded directly from the c-arm imaging device and surgical times were defined as incision to wound closure. Percentages of patients achieving each component placement goal, as well as reaching all three accuracy goals, were also evaluated. Continuous variables were non-parametric, therefore, group differences were determined by the Mann-Whitney U test and categorical data were evaluated with the Fisher Exact test.

Click here to download the whitepaper:

Some of the data in this whitepaper were previously published in the Journal of Arthroplasty (DOI: 10/1016/j.arth.2020.06.053) by senior surgeon Dr. Cass Nakasone of Straub Medical Center, Bone and Joint Center, Honolulu, HI 96813. Click here to view the article on arthroplastyjournal.org.

To request a HipGrid Drone product demo or a PhantomMSK Hip software demo, please click here.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's PressSure is a battery-powered device that holds standard pressure bags at one of three fixed preset pressures during blood or IV fluid infusions.

  • 01The claims so far are design claims and an award shortlist; the signal worth watching is whether QinFlow or early adopters publish in-service data on reinflation time saved.

Oct 1, 2026

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

On I Don’t Care, BedConnect founder Lindsey Joseph and Kevin Stevenson discuss the limits of broad post-acute referrals. Their proposal is to match clinical needs, payer coverage and available beds before presenting options. CMS guidance and AHRQ discharge resources provide independent context; they do not establish BedConnect’s clinical outcomes.

  • 01BedConnect proposes matching clinical needs, payer coverage and bed availability before presenting post-acute options; this is the company’s approach, not independently validated outcome evidence.
  • 02CMS discharge-planning guidance emphasizes patient goals, treatment preferences and relevant provider quality and resource-use data.
  • 03Readmission comparisons need a defined patient group, time window and source; the interview’s roughly one-quarter/fourteen-day estimate has not been independently verified.

Sep 29, 2026

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: U.S. digital health startups raised $7.4 billion across 244 deals in H1 2026, up from $6.4 billion on 245 deals in H1 2025. The rebound is concentrated. Nineteen companies raised 20 $100 million-plus rounds that captured 45% of capital.

  • 01In H1 2026, 19 companies raised 20 mega-deals of $100 million or more, representing 45% of all capital invested, according to Rock Health.
  • 02According to Rock Health, the firm stopped labeling startups as “AI-enabled,” saying the technology is now too widespread for the label to be meaningful.

Sep 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512